Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 74OTHER 72NIH 13OTHER_GOV 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 7Thoracic 1Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 89Lung Neoplasms 79Small Cell Lung Carcinoma 28Adenocarcinoma of Lung 9Mesothelioma, Malignant 6Esophageal Neoplasms 6Carcinoma, Hepatocellular 4Adenocarcinoma 4Stomach Neoplasms 3Neoplasm Metastasis 3NSCLC 3Motor Activity 3Mesothelioma 3Meningeal Carcinomatosis 3Carcinoma, Renal Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Thymoma 2Sarcopenia 2Pleural Effusion, Malignant 2Pancreatic Neoplasms 2Neuroendocrine Tumors 2Neoplasms 2Melanoma 2Lung Diseases 2EGFR Positive Non-small Cell Lung Cancer 2Disease 2Colorectal Neoplasms 2Weight Loss 1Untreated Advanced Non-small Cell Lung Cancer 1

Interventions

Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Kidney Neoplasms × Thoracic × Clear all
NCT07485114 2026-03-20

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Tel-Aviv Sourasky Medical Center

Recruiting
300 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡